Dengue Fever in Bangladesh
Dengue fever is a severe virus that claims the lives of hundreds of thousands of people every single year. It is present in over 100 countries worldwide, including the Philippines, Honduras and Sri Lanka; however, the country of Bangladesh is currently experiencing the worst outbreak in history.

Not only is dengue fever in Bangladesh a serious threat, but according to the World Health Organization (WHO), the virus is now a rising threat to the entire world.

What is Dengue Fever?

Mosquito bites spread the virus dengue fever. There are multiple strands and severities of the sickness, including severe dengue, which is the deadliest. Symptoms of dengue, which include a fever accompanied by a rash, nausea, vomiting and pain, can last up to seven days. Severe Dengue will make itself manifest within 24-48 hours of infection and generally occur after the fever has dissipated. These symptoms are more severe in nature and include pain, vomiting blood, bleeding from the nose or gums, fatigue, irritability and restlessness.

One of the Top 10 Threats to Global Health

Although dengue specifically affects mosquito prone areas, these areas still include over 100 countries worldwide and 300 million people. This equates to almost 40 percent of the world’s population who are at risk of contracting dengue.

Every year, the virus infects close to 400,000 individuals. From there, over 22,000 die from severe dengue. This virus has slowly increased in prevalence and severity throughout the years, and in 2019 the World Health Organization (WHO) announced that dengue fever is one of the top 10 threats to global health in 2019. The organization explained this was not only due to the hundreds of thousands of cases that emerge every single year, resulting in horrible death tolls across multiple countries but also because the prevalence of dengue has increased 30 percent in the last 50 years.

What is Happening in Bangladesh?

Bangladesh is currently experiencing the worst outbreak of dengue fever to date. Dengue has been a growing threat for decades, with longer seasons of infection, rising death tolls and changing symptoms. Now, dengue has infected Bangladesh with previously unforeseen ferocity.

Since January 2019, there have been almost 40,000 cases of dengue in Bangladesh alone. The virus has spread throughout all of Bangladesh, but over 86 percent of cases of dengue fever come from the capital, Dhaka. The number of reported deaths in Bangladesh due to dengue is 29. However, that number could be much higher. This is due to the difficulties of determining if a death was the direct cause of dengue. Without proper blood samples and information from those who pass away, determining if a death was the direct cause of dengue is impossible.

Efforts to Aid the Dengue Fever Situation

With such a severe outbreak in the country, Bangladesh is doing all it can to ensure the health of its people. For example, The Communicable Disease Control (CDC) unit of The Directorate of General Health Services (DGHS) releases regular updates on the situation of dengue fever in Bangladesh in order to inform the public of the outbreak and it is doing. It reported that as of August 2019, almost 30,000 dengue patients were able to go home since the beginning of the outbreak. On the other hand, there are almost 10,000 currently admitted patients, and this number is rising by the hundreds every single day.

In order to combat dengue, the DGHS has implemented several strategies. At the beginning of August 2019, doctors in all 64 districts of Bangladesh received training on dengue treatment and management. The DGHS is also focusing on informing the public of prevention measures against dengue by sending messages of awareness through various media platforms and informing journalists in media briefings on various preventative measures.

Dengue fever is a severe and often fatal illness, and a serious threat to global health. Bangladesh is not the only country at risk, and the outbreak of dengue fever in Bangladesh could very well develop in countless more countries. Without serious attention given to the treatment and eradication of this virus, dengue fever will continue to claim more and more lives.

– Melissa Quist
Photo: Flickr

Living Conditions in Timor-Leste
Timor-Leste or East Timor, a small island between Indonesia and Australia, has struggled with gaining independence since its colonization in the 16th century. The long-standing political turmoil which placated the country throughout much of its history has impacted its economy. The overarching lack of access to raw materials, such as clean water, also depicts the nation’s struggling economy. Below is a list of 10 facts about living conditions in Timor-Leste.

Top 10 Facts About Living Conditions in Timor-Leste

  1. Housing: World Bank estimates from 2016 assumed that Timor-Leste’s economy and its building of national infrastructure would increase steadily over the subsequent three years. It predicted that the growth of the nation would decrease to four percent in 2017, bounce back up to five percent in 2018 and hit six percent in 2019. Unfortunately, the situation concerning Timor-Leste’s housing has remained stagnant. Most people’s houses consist of bamboo, wood and a thatched roof. People that live in urban areas are able to use concrete, which shows a divide in the living conditions in Timor-Leste.
  2. Education: Approximately 20 percent of preschool-aged children in Timor-Leste attend school and nearly 37 percent of young adults living in rural areas are illiterate compared to the six percent in urban areas. Sanitation and access to clean, drinkable water are sorely lacking in schools alone. In 2008, UNICEF began partnering with local agencies to end this issue. It advocated for the establishment of the Basic Law of Education in 2008, the Basic Education Law in 2010 and the National Policy Framework for Preschool Education in 2014 among others.

  3. Agriculture: Agriculture accounts for 80 percent of Timor Leste’s income; its main products include maize, rice and cassava. Very few of the farmers have access to sustainable technologies or practices that are necessary for efficient agricultural production. USAID implemented a plan to address this developmental disparity from 2013 to 2018 through its partnership with Developing Agricultural Communities (DAC). This partnership works with local sectors to teach horticulture technologies and the 349 participating farmers saw great results. Original participants saw their production increase by 183 percent and total revenue by 186 percent, while farmers new to the DAC increased production by 466 to 517 percent.

  4. Access to Food: Due to the heavy reliance on agriculture for survival and income, droughts and shortages of food production can result in high levels of starvation. The 2017 Global Hunger Index classifies Timor-Leste as suffering from high levels of malnutrition. Since 2001, the number of undernourished people has remained stagnant at 300,000. The Sustainable Agriculture Productivity Improvement Project (SAPIP) aims to improve incomes in addition to food and job security to the rural areas of Timor-Leste. It has a six-year-plan agreed upon by the World Bank and government in 2016 and predictions dictate that it should impact 16,500 households and approximately 100,000 people.

  5. Employment: While a majority of the population’s jobs consist of agriculture and farming, there is a huge job market in the science and technology fields. The employment rate is one of the highest that the country has seen in 10 years at 97 percent. This illustrates that while Timor-Leste may be a poor country, it has a lot of untapped potential.

  6. Medicine: Access to doctors and basic medicine has improved over recent years, but many rural communities still seek basic services. New organizations are currently emerging to improve supply chain management of pharmaceutical supplies. There are only 175 doctors that serve the entire population of Timor-Leste. Similar to the United States, citizens have a choice of whether to invest in private or public health care and the government monitors both.

  7. Mosquito-Borne Diseases: Although water surrounds Timor-Leste, the water conditions are poor which make it very easy to contract diseases. The lack of sanitation and regular garbage collection contribute to attracting mosquitoes. Dengue fever and malaria are two of the most common mosquito-borne diseases in Timor-Leste and both have a high mortality rate. Currently, there is no treatment for dengue fever in the area, but there are multiple courses of medical treatment available for malaria.

  8. Water Conditions: Timor-Leste is an island nation, but there is an overall lack of access to clean water that plagues much of the population. Access to clean water and toilets remain a constant issue in Timor-Leste as 353,000 people do not have access to clean water. Subsequently, over half of the population does not have a decent toilet which can lead to major health major issues. In fact, 65 children die each year from dirty water and unsanitary toilets. Women also suffer from managing menstruation, which can greatly inhibit their academic achievements and widen the blatant gender inequality within the country. WaterAid Australia is working tirelessly with the government to make clean water, toilets and good hygiene a part of daily life. The program, which started in 2015, has grown to support WASH delivery service projects in over 180 countries, providing services to approximately 25,000 people.

  9. Plan International: This organization works with various communities across Timor-Leste to provide access to clean water as well as to raise awareness of the importance of handwashing and waste management. Since 2011, it has built 32 village water supply systems which have benefited over 9,000 individuals.

  10. UNFPA Timor-Leste: Maternal health is an issue that has largely slipped through the cracks. In 2010, reports stated that for every 100,000 births in the country, 150 died from complications involving childbirth and pregnancy. Hemorrhaging, anemia, infections/sepsis, labor obstructions and unsafe abortions are the major causes of maternal death. Below are the four pillars that UNFPA works hard to ensure are available to all women:

    1. Modern Contraceptives: Birth control, condoms, etc.

    2. Antenatal care: Routine health screenings of pregnant women without symptoms in order to diagnose diseases or complicating obstetric conditions.

    3. Safe Delivery: A delivery in a medical setting or by a midwife, in which health professionals monitor both the mother and baby.

    4. Emergency Obstetric Care: Basic emergency obstetric and newborn care is critical to reducing maternal and neonatal death.

With the increase of birth rates and access to clean water and food, there is no question that progress is occurring in Timor-Leste. Improvements are slowly diminishing the fatal health issues in the country as these 10 facts about living conditions in Timor-Leste have illustrated.

Joanna Buoniconti
Photo: Flickr

insecticide removes malaria-spreading mosquitoesScientists from the University of California, Riverside have discovered that a new type of insecticide removes malaria-spreading mosquitoes safely. Unlike common insecticides, this new technology is comprised of a neurotoxin (PMP1) that is toxic to the Anopheles but has no effect on humans or any other living organism. The development of this insecticide is a leap forward for the scientific community, as it has the potential to drastically reduce the number of individuals—roughly 220 million—who contract malaria each year.

Impact of Malaria

Malaria is one of the world’s deadliest diseases. Scientists estimate that malaria kills over 425,000 individuals per year, mainly those living in South America, Africa, and South Asia. Children and pregnant women are at the greatest risk for malaria transmission because pregnancy decreases immunity and children have not yet developed partial immunity. However, cases occur in individuals of all ages and gender. One of the most common and effective solutions for malaria prevention is to provide individuals with bed nets to prevent mosquito bites during sleep. The most foolproof method is the treatment of bed nets with an insecticide that kills mosquitoes on contact. Past insecticides have shown some negative side effects such as rashes, blisters and itching. The new proposed insecticide removes malaria-spreading mosquitoes with PMP1 and has no side effects, making it a safe way to protect individuals from the Anopheles mosquito.

Finding and Isolating the Bacteria

While the development of the PMP1 insecticide is a relatively new innovation, scientists have long understood the ability of the Paraclostridium Bifermentans bacteria to subdue the Anopheles mosquito. However, they have been unable to understand the protein that enables this protection in the past. Sarjeet Gill, professor of molecular, systems, and cell biology at the University of California, Riverside, led a research team to study this effect. The team placed the bacteria under radiation, creating several strains of Paraclostridium Bifermentans that could not produce PMP1. They compared these radiated nontoxic strains to the non-radiated toxic strains, which helped them identify PMP1, the protein in the toxic strains that is lethal to the Anopheles. They plan to use PMP1 to produce the insecticide.

The team has applied to patent their new discovery and are looking for partners to help them develop and manufacture the new insecticide for use in countries with high malaria risk. The insecticide has immense promise with no negative side effects, and because it is plant-based, not synthetic chemical-based. This means that it is highly unlikely that the Anopheles will develop a resistance to the insecticide.

Conclusion & Impact on the Global Poor

The new insecticide laced with PMP1 has the potential to drastically improve living conditions for those at risk of malaria transmission. Malaria affects millions of individuals living in poverty every year, as many of these individuals do not have access to proper insecticide-treated bed nets. However, the when new insecticide removes malaria-spreading mosquitoes, it should provide an easy and affordable way to ensure that individuals living in poverty will be protected without negative side effects and with a very minimal chance of the Anopheles mosquito developing resistance. The insecticide is an extremely promising innovation, one that has the potential to end the spread of malaria.

– Kiran Matthias
Photo: Wikimedia

Malaria in Burkina Faso
Starting every July, citizens of Burkina Faso prepare themselves. While some prepare for a harvest or the school year to begin, many prepare for mosquitoes. Peak mosquito and peak malaria season begin in July and runs through September.

Malaria is a serious burden on the Burkinabé people. In 2015, the disease, which is treatable and preventable, was responsible for 61.5 percent of hospitalizations and 30.5 percent of deaths in Burkina Faso. That same year, malaria accounted for roughly 70 percent of deaths in children under the age of 5. In 2018, there were 11,915,816 presumed and confirmed cases of malaria. While reports say that 4,144 people died of malaria in 2018, experts estimate the true total to be above 30,000.

However, change is on the horizon. Recently, the nonprofit research group Target Malaria began testing its newest weapon against malaria: mosquitoes.

Using Mosquitoes to fight Malaria in Burkina Faso

In the small village of Bana, 10,000 genetically modified, sterile male mosquitoes, coated in fluorescent dust, were released into the wild. Although mosquitoes have been genetically modified in Brazil and the Cayman Islands, this was the first time such mosquitoes have been released in Africa, and out in the world.

This release was a long time in the making. Target Malaria, led by Abdoulaye Diabaté, began research in 2012. However, in the seven years it took to reach this point, far more was needed than just research. Diabaté and his research team also sought to bring in the community. Such an experiment was sure the bring skepticism and criticism from local tribes, so Target Malaria sought the approval of tribe leaders before letting the mosquitoes into the wild. In May 2018, all of the tribe leaders signed off on the project, giving their approval.

The overall goal of Target Malaria’s research is to develop a special gene in mosquitoes that will squash the malaria gene, effectively eradicating malaria in Burkina Faso and wherever else the mosquitoes reach.

This first release is a stress test. Over 99 percent of the mosquitoes released are sterile males, which cannot bite and pass on their genes. Scientists wanted to test how these mosquitoes fare in the wild, track their behaviors, flight patterns and flight dispersal, as well as see how the ecosystem reacts to these new mosquitoes. The mosquitoes should die within a matter of months.

The next step for Target Malaria is research and analysis. According to Diabaté, the team plans to spend the next year working with information from this stress test. Then, they will continue to develop the malaria-squashing gene, as well as continue to build community relations. The remaining scientific research component should be completed in two to three years. However, because of developing community relationships and education processes, the group expects the mosquitoes equipped with the gene to be released in six or seven years.

Because of the nature of this project, Target Malaria has not been without criticism. Environmentalists warn of the dangers of tampering with an entire species of mosquito and the possibility of unforeseen consequences. According to Diabaté, the group understands this but also highlight the tremendous possibilities if the project is successful. There are 3,500 different species of mosquito in Africa and 850 in West Africa alone. Target Malaria is attacking one species of mosquito and possibly saving thousands, if not millions of lives from malaria in Burkina Faso and the rest of Africa. For Target Malaria, the risk is worth the reward.

What is Target Malaria?

Target Malaria is a nonprofit research group that aims to develop and share technology for malaria control in Africa. The team’s vision is to create a world free of malaria. The team consists of scientists, stakeholder engagement teams, risk assessment teams and regulatory experts from Africa, Europe and North America. They operate from Burkina Faso, Mali and Uganda.

Diabaté himself is a native of Burkina Faso and is familiar with malaria after suffering through it himself. His wife, children and sibling have also suffered bouts with malaria as well. Malaria in Burkina Faso is a far too common issue for his family and millions of others.

The research Target Malaria is doing has the possibility of eradicating malaria. If successful, the genetically modified mosquitoes will replace the standard bed nets and medical treatments. These mosquitoes have the potential to change the lives of millions throughout Africa.

– Andrew Edwards
Photo: Wikimedia Commons

Reducing Malaria in Liberia
The Republic of Liberia, located on the western coast of Africa and bordered by Sierra Leone and Guinea, has a population of 4.7 million people. About 50 percent of the population, or 2.35 million people, fall below the national poverty line, meaning that they have less than $2.00 a day on their disposal.

Liberia Health Care System

Liberia’s health care system suffered a lot after a 14-year civil war that ended in 2003. Almost 95 percent of doctors were lost or were forced out of the country after the war, leaving staff shortages throughout the nation, and hospitals and other health care services were confined to the capital city of Monrovia. Organizations such as Hospitals of Hope that donated $1.1 million worth of medical supplies to the JFK Hospital, helped Liberia’s health care system recover after the civil war.

Malaria in Liberia

Although Liberia’s health care system continues to improve, the civil war left the country susceptible to many communicable diseases, including HIV/AIDS, diarrhea, respiratory illnesses and malaria. Malaria is the number one cause of inpatient death in Liberia, accounting for 44 percent of all inpatient deaths among children. In 2016, the prevalence of malaria parasitemia in children under the age of 5 was on average 45 percent. This number is even higher in some areas in the country, reaching levels over 60 percent.

President’s Malaria Initiative

In order to reduce malaria in Liberia, USAID works with the U.S. Centers for Disease Control and Prevention to implement the President’s Malaria Initiative (PMI). PMI first started in 2005 as a five-year program, intending to reduce malaria in Liberia by 50 percent. However, after 14 years and a 70 percent decrease in malaria, PMI created a new strategy for the period from 2015 to 2020, having in mind recent progress that was achieved. The current PMI strategy has a long-term goal of complete malaria elimination.

In Liberia, PMI supports four different malaria prevention and treatment methods: diagnosing and treating malaria, supplying citizens with Insecticide Treated Nets (ITNs), preventing and managing malaria during pregnancy and monitoring malaria outbreaks. PMI also supports the Liberian Ministry of Health (MOH) after Ebola outbreaks.

When it comes to treating malaria in Liberia, every little detail counts. In April 2017, a PMI warehouse used to store medications and medical supplies caught on fire, so USAID quickly transferred these supplies to the remaining warehouse. The result was a consolidated, centralized warehouse that made security and transportation cheaper and easier. This is just one example of how USAID and PMI are logistically jointly working to reduce malaria in Liberia. The goal of PMI in the following years is to reduce malaria-related illnesses and deaths by another 50 percent. Other goals for the benchmark year 2020 include:

  • Increasing prompt diagnosis and effective treatment by 85 percent
  • Ensuring that 80 percent of the population is protected from malaria
  • Teaching up to 95 percent of the population to the preventive measures

Since 2003, Liberia has been slowly recovering from the detrimental civil wars, and episodes of malaria, an illness that is still a lingering issue in the country, have greatly decreased. With help from organizations and programs such as USAID and PMI, the country can continue to progress in this fight until malaria in Liberia is finally gone for good.

– Natalie Dell

Photo: Flickr

Reducing the Threat of Mosquitoes
According to the World Health Organization (WHO), viruses spread by mosquitos kill an estimated 700,000 people a year. Out of the mosquito-spread viruses, dengue, Zika and chikungunya are considered some of the most dangerous due to the quickness and severity of their infection rates. Although disease prevention has proven to be expensive for developed and developing countries alike, Wolbachia is increasingly being explored as a new tool in the fight against mosquitos.

Wolbachia Bacteria

Wolbachia, a word most of us are not familiar with, is, in fact, a safe and naturally developed bacteria that is present in 60 percent of all insect species. However, Wolbachia is not found in the Aedes aegypti species of mosquito that are the primary transmitters of dengue, Zika and chikungunya to humans.

The bacteria prevent the spread and outbreak of viruses by acting as a natural competitor in the mosquito. First, Wolbachia boosts the immune systems of Aedes aegypti mosquitos and prevents viruses from being able to spread to and survive on the species. Secondly, Wolbachia effectively consumes molecules, such as cholesterol, which viruses need in order to thrive.

In other words, viruses are being prevented from spreading viruses mosquito-to-mosquito and mosquito-to-human. This bacteria has proven to be very efficient in reducing the threat of mosquitos.

The World Mosquito Program

The leader in utilizing Wolbachia against mosquito-spread viruses is the nonprofit World Mosquito Program (WMP). The WMP conducts research, works with communities, governments and other nonprofit organizations and implements the release and studying of Wolbachia bacteria in mosquito populations.

Currently, the WMP operates in 12 at-risk countries with a primary interest in economically disenfranchised countries and populations.  These 12 countries are Vietnam, India, Sri Lanka, Indonesia, Australia, Kiribati, Vanuatu, New Caledonia, Fiji, Mexico, Colombia and Brazil. According to the U.N. Development Programme, viruses such as Zika pose tremendous economic, health care and tourism risks to countries while simultaneously hurting people in poverty who have a reduced access to health and sanitation facilities.

Support in Reducing the Threat of Mosquitos

Throughout the countries mentioned above, the WMP has gained countless support from communities, governments and nonprofits. For instance, the Australian and New Zealand have worked closely together to fund the WMP projects in Fiji and Vanuatu. In Fiji, these additional funds have allowed the WMP to reach an additional 120,000 people.

A well-known U.S. nonprofit organization, the Bill and Melinda Gates Foundation, has become an important funder for the WMP projects and for developing new technology for research and operations. The U.S. Agency for International Development has proven to be a lead contributor to financing projects against Zika in Colombia, where 25 million people are at-risk to an outbreak.

Other important actors that participate in WMP programs include the U.K. and Brazilian governments, the Candeo Fund, the Wellcome Trust, local rotary clubs and many health ministries and local governments.

Results are just as vital as gaining support for reducing mosquito-spread viruses. While the WMP has not moved onto phase two by analyzing the reduction of viruses, they have collected data for the spread and sustainability of Wolbachia in mosquito populations.

Tri Nguyen Island, Vietnam, Queensland and Australia have witnessed the spread of Wolbachia to nearly 100 percent of their mosquito populations since the projects began.

Doubts about Wolbachia

While initial results look promising, there have been reasonable doubts expressed about using Wolbachia bacteria. Some studies suggest that Wolbachia enhances the ability of West Nile Virus to spread in the Culex tarsalis mosquito and that temperatures play a large role in the effectiveness of the bacteria. However, the WMP has discounted the temperature claim by referencing the success rates in Vietnam, Australia, Brazil and Colombia in reducing the threat of mosquitos.

Despite the possible consequences, the WMP has maintained its belief in the ability of Wolbachia and continuing to research and study the results as much as possible. Looking at their sponsors, the WMP has become a popular potential solution to actors affected by and interested in mosquito-spread viruses.

These sponsors are not the only ones, however, as the WHO has labeled Wolbachia as a viable tool going forward. In 2016, the organization recommended that Wolbachia should be tested in pilot programs in order to gain more beneficial evidence. In fact, their laboratory tests confirmed that Zika, Dengue and Chikungunya were reduced in mosquitos introduced to Wolbachia.

The WMP’s program is meant to be a long-term, low-cost and sustainable virus reduction solution, not the one to be used just in emergency circumstances. With that being said, Wolbachia should be part of a greater toolbox in reducing mosquito-spread viruses through prevention, containment and reduction.

To reiterate, the entomology coordinator for the WMP operations in Brazil stated to the U.N. that Wolbachia bacteria is not a silver bullet, but it is really promising.

– Tanner Helem
Photo: Flickr